Duality Advisers’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-29,580
Closed -$6.46M 302
2024
Q1
$6.46M Buy
29,580
+17,323
+141% +$3.82M 0.64% 17
2023
Q4
$2.79M Buy
+12,257
New +$2.57M 0.29% 110
2023
Q2
Sell
-23,943
Closed -$4.72M 638
2023
Q1
$4.72M Buy
+23,943
New +$4.93M 0.53% 27
2022
Q4
Sell
-5,925
Closed -$1.04M 689
2022
Q3
$1.04M Buy
+5,925
New +$1.21M 0.11% 302
2022
Q2
Sell
-4,179
Closed -$947K 742
2022
Q1
$947K Buy
+4,179
New +$983K 0.1% 337
2021
Q4
Sell
-23,495
Closed -$5.68M 607
2021
Q3
$5.68M Buy
+23,495
New +$5.92M 0.44% 55
2020
Q1
Sell
-41,839
Closed -$6.08M 183
2019
Q4
$6.08M Sell
41,839
-1,660
-4% -$240K 0.36% 93
2019
Q3
$6.28M Buy
+43,499
New +$6.35M 0.35% 91

Other funds holding LH

Duality Advisers's LH Position: Q2 2024 in Review

Duality Advisers sold out of Labcorp (LH) in Q2 2024, closing a stake of 29,580 shares — an estimated $6.46M sold.

Duality Advisers first reported a position in LH in Q3 2019 and held it in 8 quarters. The position peaked at $6.46M in Q1 2024. 852 funds tracked by Wall St. Rank hold LH as of Q2 2024.

  • Duality Advisers reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 29,580 Labcorp shares in Q2 2024, an estimated $6.46M.
  • Duality Advisers first reported a position in Labcorp in Q3 2019 and held it in 8 quarters.
  • Duality Advisers's Labcorp position peaked at $6.46M in Q1 2024.
  • 852 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.